• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S-1单药治疗直肠癌腹主动脉旁及盆腔侧方淋巴结复发的完全缓解

Complete Response of Para-Aortic and Lateral Pelvic Lymph Node Recurrence of Rectal Cancer Treated to S-1 Monotherapy.

作者信息

Miyazawa Tomonori, Koide Norihiko, Fujita Nobuhiro

机构信息

Department of Surgery, Joetsu General Hospital, Joetsu, Japan.

出版信息

World J Oncol. 2013 Feb;4(1):46-49. doi: 10.4021/wjon619w. Epub 2013 Mar 6.

DOI:10.4021/wjon619w
PMID:29147329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5649918/
Abstract

This report presents a case of para-aortic and lateral pelvic lymph node recurrence of rectal cancer that showed complete response to S-1 monotherapy. A 69-year-old man underwent low anterior resection for rectal cancer in 2007. Para-aortic lymph and right lateral pelvic lymph node recurrence occurred in 2008. He received a fluorouracil/folinic acid plus oxaliplatin regimen; however, G4 neutropenia and G3 fatigue were experienced. We started S-1 monotherapy as a salvage treatment. Abdominal computed tomography did not reveal any para-aortic and lateral pelvic lymph nodes recurrence after 10 cycles of S-1 monotherapy. Hence, response in this case was classified as a complete response. No recurrence was noted 36 months after the complete response. S-1 monotherapy is likely to be effective in treating patients with metastatic colorectal cancer who do not respond to standard combination chemotherapy.

摘要

本报告介绍了一例直肠癌腹主动脉旁和盆腔外侧淋巴结复发患者,该患者对S-1单药治疗显示出完全缓解。一名69岁男性于2007年接受了直肠癌低位前切除术。2008年出现腹主动脉旁淋巴结和右侧盆腔外侧淋巴结复发。他接受了氟尿嘧啶/亚叶酸加奥沙利铂方案治疗;然而,出现了4级中性粒细胞减少和3级疲劳。我们开始使用S-1单药治疗作为挽救治疗。在进行10个周期的S-1单药治疗后,腹部计算机断层扫描未显示任何腹主动脉旁和盆腔外侧淋巴结复发。因此,该病例的反应被分类为完全缓解。完全缓解36个月后未观察到复发。S-1单药治疗可能对那些对标准联合化疗无反应的转移性结直肠癌患者有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab8/5649918/a1393f975f2c/wjon-04-046-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab8/5649918/cbfa7b923fff/wjon-04-046-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab8/5649918/a1393f975f2c/wjon-04-046-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab8/5649918/cbfa7b923fff/wjon-04-046-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab8/5649918/a1393f975f2c/wjon-04-046-g002.jpg

相似文献

1
Complete Response of Para-Aortic and Lateral Pelvic Lymph Node Recurrence of Rectal Cancer Treated to S-1 Monotherapy.S-1单药治疗直肠癌腹主动脉旁及盆腔侧方淋巴结复发的完全缓解
World J Oncol. 2013 Feb;4(1):46-49. doi: 10.4021/wjon619w. Epub 2013 Mar 6.
2
Successful resection of metachronous para-aortic, Virchow lymph node and liver metastatic recurrence of rectal cancer.成功切除直肠癌异时性主动脉旁、魏尔啸淋巴结及肝转移复发灶。
World J Gastroenterol. 2015 Nov 28;21(44):12722-8. doi: 10.3748/wjg.v21.i44.12722.
3
Complete Response of Isolated Para-aortic Lymph Node Recurrence from Rectosigmoid Cancer Treated by Chemoradiation Therapy with Capecitabine/Oxaliplatin plus Bevacizumab: A Case Report.卡培他滨/奥沙利铂联合贝伐单抗同步放化疗治疗乙状结肠癌孤立性主动脉旁淋巴结复发的完全缓解:一例报告
Case Rep Oncol. 2012 May;5(2):216-21. doi: 10.1159/000338840. Epub 2012 May 3.
4
[Four Cases of Colorectal Cancer with Para-Aortic Lymph Node Metastases Successfully Resected Resulting in Long-Term Survival].四例伴有主动脉旁淋巴结转移的结直肠癌成功切除并获得长期生存
Gan To Kagaku Ryoho. 2016 Nov;43(12):1718-1720.
5
[A case of rectal cancer which showed complete response to chemotherapy for para-aortic lymph node metastases remaining after surgery, for which resection of Virchow's lymph node recurrence led to long-term survival].[一例直肠癌患者,其对手术后残留的主动脉旁淋巴结转移灶化疗显示完全缓解,因切除魏尔啸淋巴结复发灶而获得长期生存]
Gan To Kagaku Ryoho. 2013 Sep;40(9):1233-6.
6
Successful conversion surgery for unresectable gastric cancer with giant para-aortic lymph node metastasis after downsizing chemotherapy with S-1 and oxaliplatin: a case report.S-1与奥沙利铂联合新辅助化疗后不可切除的伴有巨大主动脉旁淋巴结转移的胃癌成功行转化手术:一例报告
Surg Case Rep. 2018 Aug 7;4(1):88. doi: 10.1186/s40792-018-0494-4.
7
[Long-Term Survival of a Patient with Para-Aortic Lymph Node Recurrence Who Underwent Lymph Node Dissection and Received Chemotherapy Following Curative Gastrectomy].[一位接受根治性胃切除术后发生主动脉旁淋巴结复发、接受淋巴结清扫及化疗患者的长期生存情况]
Gan To Kagaku Ryoho. 2019 Apr;46(4):745-747.
8
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
9
[A Case of Isolated Lateral Pelvic Lymph Node Recurrence after TME for Early Lower Rectal Cancer Treated with Laparoscopic Lateral Lymph Node Dissection].[1例早期低位直肠癌经腹腔镜侧方淋巴结清扫术行全直肠系膜切除术后孤立性侧盆腔淋巴结复发的病例]
Gan To Kagaku Ryoho. 2018 Apr;45(4):734-736.
10
A case of marked response to preoperative chemoradiotherapy for rectal cancer with para-aortic lymph node metastasis.
Int Surg. 2011 Apr-Jun;96(2):139-43. doi: 10.9738/1389.1.

本文引用的文献

1
Complete response of liver metastasis of gastric cancer treated by s-1 chemoradiotherapy: a case report.S-1 同步放化疗治疗胃癌肝转移的完全缓解:一例报告
Case Rep Oncol Med. 2012;2012:368428. doi: 10.1155/2012/368428. Epub 2012 Aug 13.
2
Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapy.挽救性 S-1 单药治疗在伊立替康或奥沙利铂为基础化疗失败的转移性结直肠癌患者中的应用。
Med Oncol. 2011 Dec;28 Suppl 1:S291-4. doi: 10.1007/s12032-010-9755-1. Epub 2010 Nov 30.
3
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).
伊立替康联合 S-1(IRIS)对比氟尿嘧啶、亚叶酸钙联合伊立替康(FOLFIRI)二线治疗转移性结直肠癌:一项随机 2/3 期非劣效性研究(FIRIS 研究)。
Lancet Oncol. 2010 Sep;11(9):853-60. doi: 10.1016/S1470-2045(10)70181-9. Epub 2010 Aug 12.
4
Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer.奥沙利铂联合S-1治疗转移性结直肠癌的II期研究。
Ann Oncol. 2009 May;20(5):892-6. doi: 10.1093/annonc/mdn721. Epub 2009 Jan 19.
5
Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas.口服抗癌药物S-1(替吉奥)的研发历史与概念:其临床应用价值及未来展望
Jpn J Clin Oncol. 2009 Jan;39(1):2-15. doi: 10.1093/jjco/hyn127. Epub 2008 Dec 3.
6
Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.S-1与替加氟/尿嘧啶及口服亚叶酸钙治疗转移性结直肠癌患者的回顾性研究。
Anticancer Res. 2008 May-Jun;28(3B):1779-83.
7
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.卡培他滨联合奥沙利铂与氟尿嘧啶/亚叶酸钙联合奥沙利铂作为转移性结直肠癌一线治疗的随机III期研究。
J Clin Oncol. 2008 Apr 20;26(12):2006-12. doi: 10.1200/JCO.2007.14.9898.
8
Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.奥沙利铂联合口服S-1作为转移性结直肠癌患者一线治疗的I/II期研究。
Br J Cancer. 2008 Mar 25;98(6):1034-8. doi: 10.1038/sj.bjc.6604271. Epub 2008 Mar 4.
9
A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens.在含伊立替康和奥沙利铂方案治疗失败后的转移性结直肠癌中进行S-1单药治疗的II期试验。
Br J Cancer. 2006 Dec 18;95(12):1637-41. doi: 10.1038/sj.bjc.6603468. Epub 2006 Nov 14.
10
Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma.口服S-1治疗转移性结直肠癌的II期研究。
Cancer. 2004 Jun 1;100(11):2355-61. doi: 10.1002/cncr.20277.